US Stock MarketDetailed Quotes
ELV Elevance Health
- 528.580
- -5.400-1.01%
Close Apr 30 16:00 ET
- 528.590
- +0.010+0.00%
Post 19:52 ET
122.85BMarket Cap19.94P/E (TTM)
534.600High527.110Low950.28KVolume533.680Open533.980Pre Close502.98MTurnover0.41%Turnover Ratio20.96P/E (Static)232.42MShares542.07052wk High3.03P/B122.53BFloat Cap408.04952wk Low6.07Dividend TTM231.81MShs Float542.070Historical High1.15%Div YieldTTM1.40%Amplitude16.596Historical Low529.294Avg Price1Lot Size
Elevance Health Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -69.42%1.98B | -4.02%8.06B | -95.72%-2.97B | -46.93%2.61B | -20.47%1.95B | 154.58%6.47B | 0.42%8.4B | -190.79%-1.52B | 96.65%4.92B | 45.69%2.45B |
| Net income from continuing operations | 12.23%2.25B | 1.75%5.99B | -5.25%831M | -18.65%1.3B | 13.59%1.86B | 12.65%2B | -4.24%5.89B | -25.61%877M | 6.39%1.6B | -9.27%1.63B |
| Operating gains losses | 31.47%188M | 182.88%727M | 145.08%299M | 1,000.00%121M | 30.16%164M | 7,250.00%143M | 129.20%257M | 136.31%122M | 116.42%11M | 133.78%126M |
| Deferred tax | 153.33%136M | -423.48%-602M | -454.41%-241M | 1,700.00%32M | -62.35%-138M | -165.63%-255M | -133.63%-115M | -70.18%68M | -101.64%-2M | -117.95%-85M |
| Change in working capital | -124.37%-988M | -226.48%-535M | -38.81%-4.36B | -92.49%210M | -241.99%-443M | 796.90%4.05B | -62.33%423M | -2,978.90%-3.14B | 424.77%2.8B | 471.43%312M |
| -Change in receivables | -872.41%-282M | 29.80%-1.76B | 43.50%-1.04B | -2,575.00%-428M | -139.36%-270M | 97.85%-29M | -17.40%-2.51B | -373.39%-1.83B | 86.55%-16M | 283.42%686M |
| -Change in loss and loss adjustment expense reserves | -89.87%31M | -93.90%147M | -122.60%-186M | -725.00%-250M | -39.25%277M | -71.98%306M | -4.44%2.41B | 322.05%823M | -90.38%40M | -0.22%456M |
| -Change in payables and accrued expense | -1,527.78%-257M | 99.03%1.64B | -134.07%-77M | 4,679.41%1.56B | -30.39%142M | -95.79%18M | 14.60%824M | 160.43%226M | -106.38%-34M | 0.99%204M |
| -Change in other current assets | -212.12%-1.13B | -623.61%-754M | -59.50%228M | -953.85%-411M | -462.16%-208M | -5.83%-363M | 596.55%144M | 13.28%563M | 83.40%-39M | -317.65%-37M |
| -Change in other working capital | -84.16%653M | 143.50%194M | -12.61%-3.29B | -109.07%-258M | 61.48%-384M | 561.64%4.12B | -1,029.17%-446M | -1,739.33%-2.92B | 4,690.32%2.85B | -158.29%-997M |
| Cash from discontinued operating activities | ||||||||||
| Operating cash flow | -69.42%1.98B | -4.02%8.06B | -95.72%-2.97B | -46.93%2.61B | -20.47%1.95B | 154.58%6.47B | 0.42%8.4B | -190.79%-1.52B | 96.65%4.92B | 45.69%2.45B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 27.45%-2.31B | -22.19%-5.57B | -456.06%-1.03B | 44.91%-687M | 66.80%-672M | -101.77%-3.18B | 52.69%-4.56B | 129.92%289M | 13.40%-1.25B | 58.90%-2.02B |
| Net investment purchase and sale | 52.85%-670M | -15.48%-2.7B | -372.18%-724M | 61.46%-323M | 76.13%-232M | -78.97%-1.42B | 42.36%-2.34B | 140.74%266M | -8.41%-838M | 25.23%-972M |
| Net PPE purchase and sale | 7.31%-279M | -12.50%-1.3B | -9.40%-326M | -4.59%-319M | -18.64%-350M | -18.50%-301M | -5.98%-1.15B | 12.35%-298M | -18.22%-305M | -3.51%-295M |
| Net business purchase and sale | 31.62%-1.12B | -139.14%-1.55B | 169.23%18M | 678.57%81M | 97.63%-13M | -2,585.25%-1.64B | 81.33%-649M | 23.53%-26M | ---14M | 83.95%-548M |
| Net other investing changes | -236.93%-241M | 94.30%-24M | -99.14%3M | -40.00%-126M | 63.16%-77M | 137.53%176M | 58.68%-421M | 468.85%347M | 78.00%-90M | -378.67%-209M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 27.45%-2.31B | -22.19%-5.57B | -456.06%-1.03B | 44.91%-687M | 66.80%-672M | -101.77%-3.18B | 52.69%-4.56B | 129.92%289M | 13.40%-1.25B | 58.90%-2.02B |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 106.03%32M | -154.10%-3.35B | -52.71%-394M | 20.80%-994M | -1,025.98%-1.43B | -264.91%-531M | -411.58%-1.32B | 80.38%-258M | -51.20%-1.26B | 84.51%-127M |
| Increase decrease in deposit | 203.41%212M | -125.50%-77M | 93.99%-23M | 40.00%91M | -66.48%60M | -146.49%-205M | -68.41%302M | -417.57%-383M | -83.25%65M | 301.12%179M |
| Net issuance payments of debt | 9.14%764M | -58.83%739M | -8.89%861M | 39.24%-288M | -191.44%-534M | -5.41%700M | -23.39%1.8B | 286.76%945M | 5.20%-474M | 326.28%584M |
| Net common stock issuance | 9.00%-566M | -15.54%-2.68B | -63.38%-928M | 17.10%-480M | -3.53%-646M | -14.13%-622M | -21.89%-2.32B | -8.81%-568M | -28.38%-579M | -30.00%-624M |
| Cash dividends paid | -7.98%-379M | -13.51%-1.4B | -13.44%-346M | -13.73%-348M | -13.27%-350M | -13.59%-351M | -11.32%-1.23B | -11.72%-305M | -10.87%-306M | -11.15%-309M |
| Proceeds from stock option exercised by employees | 125.58%97M | -16.48%152M | 33.33%40M | -13.89%31M | -5.00%38M | -43.42%43M | -10.34%182M | -28.57%30M | 80.00%36M | -23.08%40M |
| Net other financing charges | 0.00%-96M | -76.92%-92M | -91.30%2M | --0 | -33.33%2M | -18.52%-96M | 30.67%-52M | 27.78%23M | 127.27%3M | 101.85%3M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 106.03%32M | -154.10%-3.35B | -52.71%-394M | 20.80%-994M | -1,025.98%-1.43B | -264.91%-531M | -411.58%-1.32B | 80.38%-258M | -51.20%-1.26B | 84.51%-127M |
| Net cash flow | ||||||||||
| Beginning cash position | -11.66%6.53B | 51.37%7.39B | 23.07%10.92B | 54.76%9.99B | 64.62%10.14B | 51.37%7.39B | -15.00%4.88B | 61.60%8.87B | 22.78%6.46B | -33.94%6.16B |
| Current changes in cash | -110.89%-300M | -134.11%-860M | -195.49%-4.39B | -61.52%932M | -150.50%-152M | 114.32%2.75B | 396.24%2.52B | -144.17%-1.49B | 935.04%2.42B | 107.41%301M |
| Effect of exchange rate changes | --0 | 92.86%-1M | -50.00%1M | 33.33%-4M | 116.67%1M | 125.00%1M | -40.00%-14M | 300.00%2M | -200.00%-6M | 0.00%-6M |
| End cash position | -38.61%6.23B | -11.66%6.53B | -11.66%6.53B | 23.07%10.92B | 54.76%9.99B | 64.62%10.14B | 51.37%7.39B | 51.37%7.39B | 61.60%8.87B | 22.78%6.46B |
| Free cash flow | -72.45%1.7B | -6.65%6.77B | -81.55%-3.3B | -50.34%2.29B | -25.82%1.6B | 169.70%6.17B | -0.41%7.25B | -236.34%-1.82B | 105.65%4.62B | 54.29%2.16B |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg